skip to main content

    Updated Visitor Guidelines

 

MENU

 

Breast Cancer

Personalizing Treatment of Triple-Negative Breast Cancer Shows Promise in Cell Lines

A group of researchers at the U-M Rogel Cancer Center is laying the foundations for a new, “multi-omic” approach that could help determine the drugs to which a particular triple-negative tumor will be most likely to respond based on the totality of its molecular features.

Balancing Cancer Treatment with Life

Logan Moore discovered a lump while nursing her 7-month-old son. It was a devastating shock to her and her family. Throughout her treatment, Moore and her husband, Brandon, focus on making her cancer and its treatment a part of their lives while keeping their family at the center.

What Breast Cancer and Ovarian Cancer Survivors Should Know About New Genetic Testing Recommendations

Breast cancer and/or ovarian cancer survivors should be offered genetic counseling and genetic testing for BRCA1 and BRCA2 genetic mutations, according to new recommendations from the U.S. Preventive Services Task Force.

Learning to Predict Breast Cancer Metastasis

U-M Rogel Cancer Center and College of Engineering researchers found breast cancer cells that swallow up nearby stem cells, making it easier for them to invade other tissues and seed secondary tumors.

Guided imagery helps one patient find her footing during treatment

Sheron Williams was trying to cope with her breast cancer diagnosis and an inflammatory disease called sarcoidosis. Sarcoidosis is a chronic illness that impacts her liver, lungs, skin and requires portable oxygen. The stress of both of these issues sent her looking for help -- and she found it when she began using guided imagery.

Pages